Exploratory Metabolomics Study of Exhaled Breath in Pulmonary Embolism (MetabolAir)
Sponsor: University Hospital, Strasbourg, France
Terminated
recruitment difficulties
Other terminated trials from University Hospital, Strasbourg, France
- Healthy Control Subjects · Apr 2025
- Cystic Fibrosis-related Diabetes · Phase PHASE4 · Jan 2025
- Kidney Transplant Recipients · Nov 2024
- Diagnosed With Uretral Fibroscopy · Sep 2024
- Patients with Colorectal Cancer · Phase NA · Sep 2024
See all terminations from University Hospital, Strasbourg, France
Other Pulmonary Embolism trials with similar outcome
A observational or N/A phase clinical study on Pulmonary Embolism, this trial is terminated or withdrawn. The trial is conducted by University Hospital, Strasbourg, France and has accumulated 11 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated
Status: Recruiting → Terminated
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Sep 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Dec 2021 — Sep 2022 [monthly]
Not Yet Recruiting
▶ Show 6 earlier versions
-
Oct 2021 — Dec 2021 [monthly]
Not Yet Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Not Yet Recruiting
-
Sep 2019 — Aug 2020 [monthly]
Not Yet Recruiting
-
Jul 2019 — Sep 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Strasbourg, France
For direct contact, visit the study record on ClinicalTrials.gov .